(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that an overview of the Company’s business strategy will be given at the 29th Annual J. P. Morgan Healthcare Conference, being held in at the Westin St. Francis hotel in San Francisco, California. The Spectrum Pharmaceuticals presentation is at 12:00 p.m. Pacific Time on Thursday, January 13, 2011 in the California East room.
